CalciMedica, Inc.·4/A

Jun 15, 7:51 PM ET

Leheny A. Rachel 4/A

4/A · CalciMedica, Inc. · Filed Jun 15, 2023

Insider Transaction Report

Form 4/AAmended
Period: 2023-06-08
Leheny A. Rachel
DirectorCHIEF EXECUTIVE OFFICER10% Owner
Transactions
  • Purchase

    Common Stock

    2023-06-08$5.22/sh+1,000$5,2259,000 total
Footnotes (1)
  • [F1]The weighted average purchase price for the transaction reported was $5.225, and the range of prices were between $5.20 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION